Publications

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

A digital future for value added medicines

24 September 2019

Policy, Report

Open

Calls to action to improve access to value added medicines

26 February 2019

Policy, Report

Open

Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

26 February 2019

Policy, Report

Open

Joint pharmaceutical industry statement on the Commission’s proposal for a Regulation on health technology assessment (HTA)

21 June 2018

Policy

Open

Position paper on Best Procurement Practices

28 April 2018

Policy

Open

Fighting counterfeit medicines in Europe: the effect on access to medicines

14 September 2017

Policy

The implementation of the Falsified Medicines Directive, and its Delegated […]

Read more

ISPOR 2016 EU – Value Added Medicines

18 November 2016

Policy, Report

Healthcare System Inefficiencies Related To Medicines: Any Potential Room For […]

Read more

Essential Medicines for Universal Health Coverage

7 November 2016

Policy

Open

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

31 May 2016

Policy, Report

Open

Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Policy

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]

Read more

Subscribe to our newsletter